دورية أكاديمية
Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge.
العنوان: | Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge. |
---|---|
المؤلفون: | da Silva FAF; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., de Brito BB; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Santos MLC; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Marques HS; Departamento de Ciências Naturais, Universidade Estadual do Sudoeste da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., da Silva Júnior RT; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., de Carvalho LS; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., de Sousa Cruz S; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Rocha GR; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Correa Santos GL; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., de Souza KC; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Maciel RGA; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Lopes DS; Departamento de Bioquímica e Biofísica, Universidade Federal da Bahia, Salvador 40.110-100, Bahia, Brazil., Silva NOE; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., Oliveira MV; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45002175, Bahia, Brazil., de Melo FF; Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45029-094, Bahia, Brazil. freiremelo@yahoo.com.br. |
المصدر: | World journal of clinical cases [World J Clin Cases] 2021 Oct 06; Vol. 9 (28), pp. 8280-8294. |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101618806 Publication Model: Print Cited Medium: Print ISSN: 2307-8960 (Print) Linking ISSN: 23078960 NLM ISO Abbreviation: World J Clin Cases Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Publication: 2014-: Pleasanton, CA : Baishideng Publishing Group Original Publication: Hong Kong, China : Baishideng Publishing Group Co., Limited, [2013]- |
مستخلص: | The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 93 million cases and 2 million deaths in the world. SARS-CoV-2 respiratory tract infection and its main clinical manifestations such as cough and shortness of breath are well known to the scientific community. However, a growing number of studies have reported SARS-CoV-2-related gastrointestinal involvement based on clinical manifestations, such as diarrhea, nausea, vomiting, and abdominal pain as well as on the pathophysiological mechanisms associated with coronavirus disease 2019. Furthermore, current evidence suggests SARS-CoV-2 transmission via the fecal-oral route and aerosol dissemination. Moreover, studies have shown a high risk of contamination through hospital surfaces and personal fomites. Indeed, viable SARS-CoV-2 specimens can be obtained from aerosols, which raises the possibility of transmission through aerosolized viral particles from feces. Therefore, the infection by SARS-CoV-2 via fecal-oral route or aerosolized particles should be considered. In addition, a possible viral spread to sources of drinking water, sewage, and rivers as well as the possible risk of viral transmission in shared toilets become a major public health concern, especially in the least developed countries. Since authors have emphasized the presence of viral RNA and even viable SARS-CoV-2 in human feces, studies on the possible fecal-oral coronavirus disease 2019 transmission become essential to understand better the dynamics of its transmission and, then, to reinforce preventive measures against this infection, leading to a more satisfactory control of the incidence of the infection. Competing Interests: Conflict-of-interest statement: There is no conflict of interest associated with any of the senior author or other coauthors contributed their efforts in this manuscript. (©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.) |
References: | BMJ Open Gastroenterol. 2020 May;7(1):. (PMID: 32457035) Clin Infect Dis. 2016 Feb 15;62(4):477-483. (PMID: 26565003) Indian J Gastroenterol. 2020 Jun;39(3):305-306. (PMID: 32710226) Int J Infect Dis. 2020 Jun;95:433-435. (PMID: 32353545) Bol Med Hosp Infant Mex. 1988 Nov;45(11):718-28. (PMID: 3214519) Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507) J Clin Virol. 2020 Jul;128:104438. (PMID: 32405257) Emerg Infect Dis. 2020 Jul;26(7):1583-1591. (PMID: 32275497) JAMA. 2020 Aug 25;324(8):782-793. (PMID: 32648899) Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. (PMID: 32199469) Pediatr Infect Dis J. 2020 Oct;39(10):e315-e317. (PMID: 32932332) mSystems. 2020 Jul 21;5(4):. (PMID: 32694130) Lancet Gastroenterol Hepatol. 2020 Apr;5(4):335-337. (PMID: 32087098) Phys Fluids (1994). 2020 Jun 1;32(6):065107. (PMID: 32574232) J Environ Chem Eng. 2021 Feb;9(1):104870. (PMID: 33282675) Emerg Infect Dis. 2020 Sep;26(9):. (PMID: 32568661) Lancet Respir Med. 2020 Apr;8(4):420-422. (PMID: 32085846) Emerg Microbes Infect. 2020 Dec;9(1):1254-1258. (PMID: 32515685) Indian J Gastroenterol. 2020 Jun;39(3):268-284. (PMID: 32749643) Sci Rep. 2020 Oct 20;10(1):17846. (PMID: 33082472) Emerg Infect Dis. 2020 Jun;26(6):1337-1339. (PMID: 32150527) Int J Infect Dis. 2020 Nov;100:476-482. (PMID: 32949774) J Med Virol. 2020 Jun;92(6):595-601. (PMID: 32100877) N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945) JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570) JAMA Netw Open. 2020 Jun 1;3(6):e2011335. (PMID: 32525549) Emerg Microbes Infect. 2020 Dec;9(1):469-473. (PMID: 32102625) Sci Rep. 2020 Jul 29;10(1):12732. (PMID: 32728118) Emerg Microbes Infect. 2020 Dec;9(1):2707-2714. (PMID: 33259268) J Hosp Infect. 2020 Oct;106(2):226-231. (PMID: 32652214) J Med Virol. 2020 Jun;92(6):680-682. (PMID: 32124995) Gut. 2020 Jun;69(6):1141-1143. (PMID: 32102928) JGH Open. 2020 Sep 18;4(6):1162-1166. (PMID: 33043143) Sci Total Environ. 2020 Nov 15;743:140709. (PMID: 32652357) Gut. 2020 Jun;69(6):1002-1009. (PMID: 32213556) Gastroenterology. 2020 Aug;159(2):765-767.e2. (PMID: 32333911) J Hepatol. 2020 Nov;73(5):1231-1240. (PMID: 32553666) Sci Total Environ. 2021 Apr 10;764:142929. (PMID: 33131867) N Engl J Med. 2004 Apr 22;350(17):1731-9. (PMID: 15102999) N Engl J Med. 2020 Mar 5;382(10):929-936. (PMID: 32004427) Gastroenterology. 2020 Jul;159(1):81-95. (PMID: 32251668) Gut. 2020 Jun;69(6):997-1001. (PMID: 32241899) Sci Total Environ. 2020 Nov 1;741:140445. (PMID: 32599407) Environ Sci Technol Lett. 2020 May 20;7(7):511-516. (PMID: 37566285) World J Gastroenterol. 2020 May 21;26(19):2323-2332. (PMID: 32476796) Front Nutr. 2020 Nov 02;7:580551. (PMID: 33224968) J Infect Dis. 2020 Nov 9;222(11):1798-1806. (PMID: 32905595) Int J Hyg Environ Health. 2021 Jan;231:113634. (PMID: 33039922) Cancer Discov. 2020 Jun;10(6):779-782. (PMID: 32276929) Emerg Infect Dis. 2020 Aug;26(8):1920-1922. (PMID: 32421494) J Gastroenterol Hepatol. 2020 May;35(5):744-748. (PMID: 32215956) Sci Total Environ. 2020 Dec 1;746:141326. (PMID: 32768790) Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. (PMID: 32405603) Int J Infect Dis. 2020 Jul;96:19-24. (PMID: 32311451) J Autoimmun. 2020 May;109:102433. (PMID: 32113704) Liver Int. 2020 Jun;40(6):1278-1281. (PMID: 32251539) Jpn J Infect Dis. 2021 Jan 22;74(1):76-78. (PMID: 32741930) Sci Total Environ. 2020 Nov 15;743:140832. (PMID: 32679506) Water Res. 2020 Aug 15;181:115942. (PMID: 32425251) Clin Microbiol Infect. 2020 Nov;26(11):1520-1524. (PMID: 32711057) Future Microbiol. 2020 Aug;15:1101-1107. (PMID: 32795131) Gastroenterology. 2020 May;158(6):1518-1519. (PMID: 32142785) Ann Intern Med. 2020 Jun 16;172(12):832-834. (PMID: 32227141) Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G245-G252. (PMID: 32639848) Int J Biol Sci. 2020 Mar 15;16(10):1698-1707. (PMID: 32226287) J Med Virol. 2020 Oct;92(10):1938-1947. (PMID: 32311109) Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264) J Infect. 2020 Aug;81(2):318-356. (PMID: 32283149) J Med Virol. 2020 Nov;92(11):2804-2812. (PMID: 32542750) J Microbiol Immunol Infect. 2020 Jun;53(3):473-480. (PMID: 32276848) Am J Gastroenterol. 2020 May;115(5):766-773. (PMID: 32287140) Sci Total Environ. 2020 Sep 20;736:139652. (PMID: 32464333) JAMA. 2020 Apr 28;323(16):1610-1612. (PMID: 32129805) Clin Gastroenterol Hepatol. 2020 Jun;18(7):1561-1566. (PMID: 32283325) Lancet Gastroenterol Hepatol. 2020 Jun;5(6):531. (PMID: 32240618) J Med Virol. 2020 Jul;92(7):909-914. (PMID: 32222992) Eur Rev Med Pharmacol Sci. 2020 May;24(10):5772-5777. (PMID: 32495914) Sci Total Environ. 2021 Jan 20;753:141710. (PMID: 32891988) Environ Pollut. 2020 Dec;267:115485. (PMID: 33254708) J Med Virol. 2020 Oct;92(10):1807-1809. (PMID: 32330309) Nat Commun. 2020 May 29;11(1):2800. (PMID: 32472043) Sci Total Environ. 2020 Aug 1;728:138764. (PMID: 32387778) N Engl J Med. 2020 Apr 16;382(16):1564-1567. (PMID: 32182409) Pediatr Investig. 2020 Mar;4(1):48-50. (PMID: 32328338) Biomed Pharmacother. 2020 Nov;131:110678. (PMID: 32861070) Pol Arch Intern Med. 2020 Jun 25;130(6):501-505. (PMID: 32491298) Sci Total Environ. 2020 Oct 1;737:140405. (PMID: 32783878) Sci Total Environ. 2020 Nov 15;743:140621. (PMID: 32758821) Emerg Microbes Infect. 2020 Dec;9(1):2501-2508. (PMID: 33161824) Nature. 2012 Jul 25;487(7408):477-81. (PMID: 22837003) Clin Infect Dis. 2005 Oct 1;41(7):e67-71. (PMID: 16142653) JAMA. 2020 May 12;323(18):1843-1844. (PMID: 32159775) J Med Virol. 2020 Jul;92(7):833-840. (PMID: 32243607) Cell. 2020 Apr 16;181(2):271-280.e8. (PMID: 32142651) Emerg Microbes Infect. 2020 Dec;9(1):386-389. (PMID: 32065057) Chin Med J (Engl). 2020 May 5;133(9):1039-1043. (PMID: 32118639) Sci Total Environ. 2021 Jan 20;753:142298. (PMID: 33207460) J Appl Microbiol. 2019 Dec;127(6):1596-1611. (PMID: 30974505) Clin Chem. 2020 Apr 1;66(4):549-555. (PMID: 32031583) Nat Med. 2020 Apr;26(4):502-505. (PMID: 32284613) Transl Res. 2020 Dec;226:57-69. (PMID: 32827705) Nat Med. 2020 May;26(5):681-687. (PMID: 32327758) Cell Rep Med. 2020 Oct 20;1(7):100121. (PMID: 32984855) J Infect Public Health. 2020 Jul;13(7):926-931. (PMID: 32546439) Gastroenterology. 2020 May;158(6):1831-1833.e3. (PMID: 32142773) |
فهرسة مساهمة: | Keywords: COVID-19; SARS-CoV-2, Transmission; Via fecal-oral |
تواريخ الأحداث: | Date Created: 20211110 Latest Revision: 20240403 |
رمز التحديث: | 20240403 |
مُعرف محوري في PubMed: | PMC8554441 |
DOI: | 10.12998/wjcc.v9.i28.8280 |
PMID: | 34754839 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2307-8960 |
---|---|
DOI: | 10.12998/wjcc.v9.i28.8280 |